Ionizing Radiation Protein Biomarkers in Normal Tissue and Their Correlation to Radiosensitivity: Protocol for a Systematic Review
<i>Background:</i> Radiosensitivity is a significantly enhanced reaction of cells, tissues, organs or organisms to ionizing radiation (IR). During radiotherapy, surrounding normal tissue radiosensitivity often limits the radiation dose that can be applied to the tumour, resulting in subo...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/11/1/3 |
id |
doaj-0b6486700ff7468fbd2a62d69b81f725 |
---|---|
record_format |
Article |
spelling |
doaj-0b6486700ff7468fbd2a62d69b81f7252020-12-23T00:02:59ZengMDPI AGJournal of Personalized Medicine2075-44262021-12-01113310.3390/jpm11010003Ionizing Radiation Protein Biomarkers in Normal Tissue and Their Correlation to Radiosensitivity: Protocol for a Systematic ReviewAnne Dietz0Maria Gomolka1Simone Moertl2Prabal Subedi3Bundesamt für Strahlenschutz/Federal Office for Radiation Protection, Ingolstädter Landstraße 1, 85764 Oberschleissheim, GermanyBundesamt für Strahlenschutz/Federal Office for Radiation Protection, Ingolstädter Landstraße 1, 85764 Oberschleissheim, GermanyBundesamt für Strahlenschutz/Federal Office for Radiation Protection, Ingolstädter Landstraße 1, 85764 Oberschleissheim, GermanyBundesamt für Strahlenschutz/Federal Office for Radiation Protection, Ingolstädter Landstraße 1, 85764 Oberschleissheim, Germany<i>Background:</i> Radiosensitivity is a significantly enhanced reaction of cells, tissues, organs or organisms to ionizing radiation (IR). During radiotherapy, surrounding normal tissue radiosensitivity often limits the radiation dose that can be applied to the tumour, resulting in suboptimal tumour control or adverse effects on the life quality of survivors. Predicting radiosensitivity is a component of personalized medicine, which will help medical professionals allocate radiation therapy decisions for effective tumour treatment. So far, there are no reviews of the current literature that explore the relationship between proteomic changes after IR exposure and normal tissue radiosensitivity systematically. <i>Objectives:</i> The main objective of this protocol is to specify the search and evaluation strategy for a forthcoming systematic review (SR) dealing with the effects of in vivo and in vitro IR exposure on the proteome of human normal tissue with focus on radiosensitivity. <i>Methods:</i> The SR framework has been developed following the guidelines established in the National Toxicology Program/Office of Health Assessment and Translation (NTP/OHAT) Handbook for Conducting a Literature-Based Health Assessment, which provides a standardised methodology to implement the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to environmental health assessments. The protocol will be registered in PROSPERO, an open source protocol registration system, to guarantee transparency. <i>Eligibility criteria:</i> Only experimental studies, in vivo and in vitro, investigating effects of ionizing radiation on the proteome of human normal tissue correlated with radio sensitivity will be included. Eligible studies will include English peer reviewed articles with publication dates from 2011–2020 which are sources of primary data. <i>Information sources:</i> The search strings will be applied to the scientific literature databases PubMed and Web of Science. The reference lists of included studies will also be manually searched. <i>Data extraction and results:</i> Data will be extracted according to a pre-defined modality and compiled in a narrative report following guidelines presented as a “Synthesis without Meta-analyses” method. <i>Risk of bias:</i> The risk of bias will be assessed based on the NTP/OHAT risk of bias rating tool for human and animal studies (OHAT 2019). <i>Level of evidence rating</i>: A comprehensive assessment of the quality of evidence for both in vivo and in vitro studies will be followed, by assigning a confidence rating to the literature. This is followed by translation into a rating on the level of evidence (high, moderate, low, or inadequate) regarding the research question. Registration: PROSPERO Submission ID 220064.https://www.mdpi.com/2075-4426/11/1/3ionizing radiationnormal tissuebiomarkerradiotherapyradiosensitivityprotein |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Anne Dietz Maria Gomolka Simone Moertl Prabal Subedi |
spellingShingle |
Anne Dietz Maria Gomolka Simone Moertl Prabal Subedi Ionizing Radiation Protein Biomarkers in Normal Tissue and Their Correlation to Radiosensitivity: Protocol for a Systematic Review Journal of Personalized Medicine ionizing radiation normal tissue biomarker radiotherapy radiosensitivity protein |
author_facet |
Anne Dietz Maria Gomolka Simone Moertl Prabal Subedi |
author_sort |
Anne Dietz |
title |
Ionizing Radiation Protein Biomarkers in Normal Tissue and Their Correlation to Radiosensitivity: Protocol for a Systematic Review |
title_short |
Ionizing Radiation Protein Biomarkers in Normal Tissue and Their Correlation to Radiosensitivity: Protocol for a Systematic Review |
title_full |
Ionizing Radiation Protein Biomarkers in Normal Tissue and Their Correlation to Radiosensitivity: Protocol for a Systematic Review |
title_fullStr |
Ionizing Radiation Protein Biomarkers in Normal Tissue and Their Correlation to Radiosensitivity: Protocol for a Systematic Review |
title_full_unstemmed |
Ionizing Radiation Protein Biomarkers in Normal Tissue and Their Correlation to Radiosensitivity: Protocol for a Systematic Review |
title_sort |
ionizing radiation protein biomarkers in normal tissue and their correlation to radiosensitivity: protocol for a systematic review |
publisher |
MDPI AG |
series |
Journal of Personalized Medicine |
issn |
2075-4426 |
publishDate |
2021-12-01 |
description |
<i>Background:</i> Radiosensitivity is a significantly enhanced reaction of cells, tissues, organs or organisms to ionizing radiation (IR). During radiotherapy, surrounding normal tissue radiosensitivity often limits the radiation dose that can be applied to the tumour, resulting in suboptimal tumour control or adverse effects on the life quality of survivors. Predicting radiosensitivity is a component of personalized medicine, which will help medical professionals allocate radiation therapy decisions for effective tumour treatment. So far, there are no reviews of the current literature that explore the relationship between proteomic changes after IR exposure and normal tissue radiosensitivity systematically. <i>Objectives:</i> The main objective of this protocol is to specify the search and evaluation strategy for a forthcoming systematic review (SR) dealing with the effects of in vivo and in vitro IR exposure on the proteome of human normal tissue with focus on radiosensitivity. <i>Methods:</i> The SR framework has been developed following the guidelines established in the National Toxicology Program/Office of Health Assessment and Translation (NTP/OHAT) Handbook for Conducting a Literature-Based Health Assessment, which provides a standardised methodology to implement the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to environmental health assessments. The protocol will be registered in PROSPERO, an open source protocol registration system, to guarantee transparency. <i>Eligibility criteria:</i> Only experimental studies, in vivo and in vitro, investigating effects of ionizing radiation on the proteome of human normal tissue correlated with radio sensitivity will be included. Eligible studies will include English peer reviewed articles with publication dates from 2011–2020 which are sources of primary data. <i>Information sources:</i> The search strings will be applied to the scientific literature databases PubMed and Web of Science. The reference lists of included studies will also be manually searched. <i>Data extraction and results:</i> Data will be extracted according to a pre-defined modality and compiled in a narrative report following guidelines presented as a “Synthesis without Meta-analyses” method. <i>Risk of bias:</i> The risk of bias will be assessed based on the NTP/OHAT risk of bias rating tool for human and animal studies (OHAT 2019). <i>Level of evidence rating</i>: A comprehensive assessment of the quality of evidence for both in vivo and in vitro studies will be followed, by assigning a confidence rating to the literature. This is followed by translation into a rating on the level of evidence (high, moderate, low, or inadequate) regarding the research question. Registration: PROSPERO Submission ID 220064. |
topic |
ionizing radiation normal tissue biomarker radiotherapy radiosensitivity protein |
url |
https://www.mdpi.com/2075-4426/11/1/3 |
work_keys_str_mv |
AT annedietz ionizingradiationproteinbiomarkersinnormaltissueandtheircorrelationtoradiosensitivityprotocolforasystematicreview AT mariagomolka ionizingradiationproteinbiomarkersinnormaltissueandtheircorrelationtoradiosensitivityprotocolforasystematicreview AT simonemoertl ionizingradiationproteinbiomarkersinnormaltissueandtheircorrelationtoradiosensitivityprotocolforasystematicreview AT prabalsubedi ionizingradiationproteinbiomarkersinnormaltissueandtheircorrelationtoradiosensitivityprotocolforasystematicreview |
_version_ |
1724373851789328384 |